Central WA Hosp Home Infusion is categorized under Hospitals in Wenatchee, WA and active since 1962.
Central WA Hosp Home Infusion was established in 1962, and today employs 1 to 4, earning $500.000 to $999.999 per year. This is a Hospitals business, which does work in the B2C market, and is classified as a Hospitals, under code number 6216100 by the NAICS.
If you are seeking more information, feel free to contact Dixie Randall, Director at the company’s single location by writing to 1201 South Miller St, Wenatchee, Washington WA 98801 or by phoning (509) 665-6058. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Central WA Hosp Home Infusion |
| Contact Person: | Dixie Randall, Director |
| Address: | 1201 South Miller St, Wenatchee, Washington 98801 |
| Phone Number: | (509) 665-6058 |
| Website Address: | cwhs.com |
| Annual Revenue (USD): | $500.000 to $999.999 |
| Founded: | 1962 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2C (Business to Consumer) |
| Business Category: | Hospitals |
| SIC Code: | 8062 |
| NAICS Code: | 6216100 |
| Share This Business: |
Central WA Hosp Home Infusion was started in 1962 to provide professional Hospitals under the SIC code 8062 and NAICS code 6216100. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $500.000 to $999.999 per annum.
Feel free to contact Dixie Randall, Director for inquiries that concern Central WA Hosp Home Infusion by calling the company number (509) 665-6058, as your correspondence is most welcome. Additionally, the physical location of the single location of Central WA Hosp Home Infusion can be found at the coordinates 47.406269,-120.32445 as well as the street address 1201 South Miller St in Wenatchee, Washington 98801.
For its online presence, you may visit Central WA Hosp Home Infusion’s website at cwhs.com and engage with its social media outlets through on Twitter and on Facebook.